Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
WORKING PAPERS
April 11, 2024
POLICY PAPERS
April 15, 2024
CGD NOTES
April 08, 2024
WORKING PAPERS
April 04, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
POLICY PAPERS
April 08, 2024
The global locus of undervaccination is increasingly shifting from the poorest countries in the world—which are eligible for support from Gavi, the Vaccine Alliance—to middle-income countries (MICs) that do not qualify for traditional Gavi support. Given these growing challenges, Gavi must rethink i...
POLICY PAPERS
September 05, 2023
The G20 is well placed to provide the leadership needed to ensure that research is a global public good by elevating the discourse on research publishing reform and acknowledging that this is not merely a niche concern for researchers but an important global challenge that underpins human progress.
POLICY PAPERS
August 07, 2023
A main driver of antimicrobial resistance is the misuse and overuse of antimicrobials. But lack of access to antimicrobials causes a large mortality burden and contributes to the spread of resistant infections. How can learnings from the use of control policies in other areas of medicine be translat...
POLICY PAPERS
February 27, 2023
Health aid has helped domestic financing achieve historic gains in global health but there is much still to be done. Six major issues prevent aid from being more effective, fit for the future, and aligned with country priorities: funding volatility, aid fragmentation, the displacement of domestic fi...
POLICY PAPERS
November 28, 2022
The experience of the COVID-19 pandemic—in the US and around the world—highlights the potential feasibility and importance of biomedical R&D for global health and welfare. Drawing from this experience and momentum, this paper argues that the US should deepen its engagement and ambition in global hea...
POLICY PAPERS
November 15, 2022
Antimicrobial drugs form the backbone of modern medicine. Yet over time, use of these drugs selects for mutations that survive exposure to those same drugs, driving “antimicrobial resistance,” or AMR. In the absence of sufficient R&D investment for new antimicrobials, deaths from drug-resistant infe...
POLICY PAPERS
November 10, 2022
Laboratories are fundamental components of health systems, but investments in strengthening laboratory systems are often inconsistent and inadequate in African countries. This paper qualitatively establishes the complex costs and benefits of strengthening laboratory capacity and systems within and a...